Welcome to visit Zhongnan Medical Journal Press Series journal website!

Relationship between Helicobacter pylori and immune dermatosis

Published on Nov. 30, 2021Total Views: 5945 timesTotal Downloads: 3201 timesDownloadMobile

Author: Xin-Yan ZHAO 1 Hong-Yu REN 2 Ai-Ping FENG 3

Affiliation: 1. Department of Spleen and Stomach Diseases, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430061, China 2. Division of Gastroenterology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China 3. Department of Dermatology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

Keywords: Helicobacter pylori Dermatosis Inflammation Immunity Eradication

DOI: 10.12173/j.issn.1004-5511.202011031

Reference: 郑晗晗, 江学良. 生物制剂治疗克罗恩病的研究进展[J]. 医学新知, 2021, 31(6): 447-454. DOI: 10.12173/j.issn.1004-5511.202011054. Zheng HH, Jiang XL. Advances in the study of biological agents in the treatment of Crohn's disease[J]. Yixue Xinzhi Zazhi, 2021, 31(6): 447-454. DOI: 10.12173/j.issn.1004-5511.202011054.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Infection with Helicobacter pylori (Hp) can result in imbalance in the immune system in humans. The long-term interaction of immunity between host and bacteria leads to loss of the skin au-toantigen tolerance, leading some immunological dermatoses. The eradication of Hp has been shown to relieve symptoms in some chronic immune skin diseases, such as urticaria, rosacea, psoriasis and auto-immune bullous disease,. However the relationship between Hp infection and Behcet's disease, sclero-derma, alopecia areata and allergic purpura is still controversial. This review focuses on the relationship between Hp infection and common immune skin diseases.

Full-text
Please download the PDF version to read the full text: download
References

1.Tsay FW, Hsu PI. H. pylori infection and extra-gastroduodenal diseases[J]. J Biomed Sci, 2018, 25(1): 65. DOI: 10.1186/s12929-018-0469-6.

2.Alshareef SA, Rayis DA, Adam I, et al. Helicobacter pylori infection, gestational diabetes mellitus and insulin resistance among pregnant Sudanese women[J]. BMC Res Notes, 2018, 11(1): 517. DOI: 10.1186/s13104-018-36 42-9.

3.Pedullà M, Fierro V, Del Tufo E, et al. Helicobacter pylori immunization and atopic dermatitis in South Italian children[J]. United European gastroenterol J, 2014, 2(4): 263-267. DOI: 10.1177/2050640614544314.

4.Blosse A, Lehours P, Wilson KT, et al. Helicobacter: inflammation, immunology, and vaccines[J]. Helicobacter, 2018, 23 Suppl 1: e12517. DOI: 10.1111/hel.12517.

5.牛占岳, 宋志强, 周丽雅. 中国大陆地区成人幽门螺杆菌耐药情况及变迁[J]. 中华内科杂志, 2016, 55(9): 734-736. DOI: 10.3760/cma.j.issn.0578-1426. 2016.09.018. [Niu ZY, Song ZQ, Zhou LY. Antimicrobial resistance of Helicobacter pylori in adults in Chinese mainland and its changes[J]. Chinese Journal of Internal Medicine, 2016, 55(9): 734-736.]

6.Mentis A, Lehours P, Mégraud F. Epidemiology and diagnosis of Helicobacter pylori infection[J]. Helicobacter, 2015, 20 Suppl 1: 1-7. DOI: 10.1111/hel.12250.

7.杨舒, 张雷. 幽门螺旋杆菌致病与免疫机制的研究进展[J]. 中国病原生物学杂志, 2017, 12(3): 283-285. DOI: 10.13350/j.cjpb.170320. [Yang S, Zhang L. Advances in the study of pathogenic and immunologic mechanisms of Helicobacter pylori infection[J]. Journal of Parasitic Biology, 2017, 12(3): 283-285.]

8.Holster IL, Vila AM, Caudri D, et al. The impact of Helicobacter pylori on atopic disorders in childhood[J]. Helicobacter, 2012, 17(3): 232-237. DOI: 10.1111/j.152 3-5378.2012.00934.x.

9.Corrado G, Luzzi I, Pacchiarotti C, et al. Helicobacter pylori seropositivity in children with atopic dermatitis as sole manifestation of food allergy[J]. Pediatr Allergy Immunol, 2000, 11(2): 101-105. DOI: 10.1034/j.1399-30 38.2000.00028.x.

10.Murakami K, Fujioka T, Nishizono A, et al. Atopic dermatitis successfully treated by eradication of Helicobacter pylori[J]. J Gastroenterol, 1996, 31 Suppl 9: 77-82. 

11.Di Campli C, Gasbarrini A, Nucera E, et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria[J]. Dig Dis Sci, 1998, 43(6): 1226-1229. DOI: 10.1023/A:1018851623109.

12.Schnyder B, Helbling A, Pichler WJ. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection[J]. Int Arch Allergy Immunol, 1999, 119(1): 60-63. DOI: 10.1159/000024176.

13.Başkan EB, Türker T, Gülten M, et al. Lack of correlation between Helicobacter pylori infection and autologous serum skin test in chronic idiopathic urticaria[J]. Int J Dermatol, 2005, 44(12): 993-995. DOI: 10.1111/j.1365-4632.2005.02280.x.

14.Kohli S, Mahajan VK, Rana BS, et al. Clinicoepidemiologic features of chronic urticaria in patients with versus without subclinical Helicobacter pylori infection: a cross-sectional study of 150 patients[J]. Int Arch Allergy Immunol, 2018, 175(1-2): 114-120. DOI: 10.1159/000485893.

15.Sugrañes-Montalván A, Barreto-Suárez E, Nicolau-Pestana E, et al. Relation between Helicobacter pylori infection and chronic urticaria[J]. Rev Alerg Mex, 2017, 64(4): 396-402. DOI: 10.29262/ram.v64i4.283.

16.Pawłowicz R, Wytrychowski K, Panaszek B. Eradication of Helicobacter pylori, as add-on therapy, has a significant, but temporary influence on recovery in chronic idiopathic urticaria: a placebo-controlled, double blind trial in the Polish population[J]. Postepy Dermatol Alergol, 2018, 35(2): 151-155. DOI: 10.5114/ada.2018.75236.

17.王迪. 慢性荨麻疹临床分析及生活质量调查[D]. 郑州: 郑州大学, 2019. [Wang D. Clinical analysis and quality of life survey of chronic urticaria[D]. Zhengzhou: Zhengzhou University, 2019.]

18.Herbarth O, Bauer M, Fritz GJ, et al. Helicobacter pylori colonisation and eczema[J]. J Epidemiol Community Health, 2007, 61(7): 638-640. DOI: 10.1136/jech.2006. 046706.

19.王强, 武亦阁, 刘淑珍, 等. 101例湿疹患者中医证型与幽门螺旋杆菌感染的临床调查[J]. 新疆中医药, 2018, 36(4): 63-64. DOI: CNKI:SUN:XJZY.0.2018-04-029. [Wang Q, Wu YG, Liu SZ, et al. Clinical investigation of 101 cases of eczema patients with TCM syndrome types and Helicobacter pylori infection[J]. Xinjiang Journal of Traditional Chinese Medicine, 2018, 36(4): 63-64.]

20.Behrangi E, Mansouri P, Agah S, et al. Association between Helicobacter pylori infection and alopecia areata: a study in iranian population[J]. Middle East J Dig Dis, 2017, 9(2): 107-110. DOI: 10.15171/mejdd.2017.59.

21.Campuzano-Maya G. Cure of alopecia areata after eradication of Helicobacter pylori: a new association?[J] World J Gastroenterol, 2011, 17(26): 3165-3170. DOI: 10.3748/wjg.v17.i26.3165.

22.Rebora A, Drago F, Picciotto A. Helicobacter pylori in patients with rosacea[J]. Am J Gastroenterol, 1994, 89(9): 1603-1604. DOI: 10.1007/BF00206946.

23.Szlachcic A, Sliwowski Z, Karczewska E, et al. Helicobacter pylori and its eradication in rosacea[J]. J Physiol Pharmacol, 1999, 50(5): 777-786. DOI: 10.1007/s002329900601.

24.Jørgensen AR, Egeberg A, Gideonsson R, et al. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis[J]. J Eur Acad Dermatol Venereol, 2017, 31(12): 2010-2015. DOI: 10.1111/jdv.14352.

25.Yang X. Relationship between Helicobacter pylori and rosacea: review and discussion[J]. BMC Infect Dis, 2018, 18(1): 318. DOI: 10.1186/s12879-018-3232-4.

26.Saleh P, Naghavi-Behzad M, Herizchi H, et al. Effects of Helicobacter pylori treatment on rosacea: a single-arm clinical trial study[J]. J Dermatol, 2017, 44(9): 1033-1037. DOI: 10.1111/1346-8138.13878.

27.Kountouras J, Zavos C, Gavalas E, et al. Helicobacter pylori may be a common denominator associated with systemic and multiple sclerosis[J]. Joint Bone Spine, 2011, 78(2): 222-223. DOI: 10.1016/j.jbspin.2011.01.006.

28.Radić M, Kaliterna DM, Bonacin D, et al. Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis?[J]. Rheumatol Int, 2013, 33(11): 2943-2948. DOI: 10.1007/s00296-012-2585-z.

29.Efthymiou G, Liaskos C, Simopoulou T, et al. Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosis[J]. Immunol Res, 2020, 68(1): 39-47. DOI: 10.1007/s12026-020-09124-w.

30.Mesquita PM, Diogo A Filho, Jorge MT, et al. Relationship of Helicobacter pylori seroprevalence with the occurrence and severity of psoriasis[J]. An Bras Dermatol, 2017, 92(1): 52-57. DOI: 10.1590/abd1806-4841.20174880.

31.Onsun N, Arda Ulusal H, Su O, et al. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment[J]. Eur J Dermatol, 2012, 22(1): 117-120. DOI: 10.1684/ejd.2011.1579.

32.Yong WC, Upala S, Sanguankeo A. Association between psoriasis and Helicobacter pylori infection: a systematic review and meta-analysis[J]. Indian J Dermatol, 2018, 63(3): 193-200. DOI: 10.4103/ijd.IJD_531_17.

33.Avci O, Ellidokuz E, Simşek I, et al. Helicobacter pylori and behcet's disease[J]. Dermatology, 1999, 199(2): 140-143. DOI: 10.1159/000018221.

34.Okano A, Ohana M. Gastrointestinal: improvement of refractory oral ulcer of behcet's disease after eradication of Helicobacter pylori[J]. J Gastroenterol Hepatol, 2018, 33(3): 560. DOI: 10.1111/jgh.13979.

35.Ersoy O, Ersoy R, Yayar O, et al. H pylori infection in patients with behcet's disease[J]. World J Gastroenterol, 2007, 13(21): 2983-2985. DOI: 10.3748/wjg.v13.i21.2983.

36.Cakmak SK, Cakmak A, Gül U, et al. Upper gastroin-testinal abnormalities and Helicobacter pylori in behcet's disease[J]. Int J Dermatol, 2009, 48(11): 1174-1176. DOI: 10.1111/j.1365-4632.2009.04145.x.

37.蔡华波, 李永柏, 赵辉, 等. 根除幽门螺杆菌疗法治疗过敏性紫癜患儿的预后分析[J]. 中国当代儿科杂志, 2014, 16(3): 234-237. DOI: 10.7499/j.issn.1008-8830. 2014.03.003. [Cai HB, Li YB, Zhao H, et al. Prognostic analysis of children with Henoch-Schonlein purpura treated by Helicobacter pylori eradication therapy[J]. Chinese Journal of Contemporary Pediatrics, 2014, 16(3): 234-237.]

38.Xiong LJ, Tong Y, Wang ZL, Mao M. Is Helicobacter pylori infection associated with Henoch-Schonlein purpura in Chinese children? a meta-analysis[J]. World J Pediatr, 2012, 8(4): 301-308. DOI: 10.1007/s12519-012-0373-1.

39.Rifaioğlu EN, Aydoğan F, Bülbül Şen B, et al. Investigation into the frequency of Helicobacter pylori infection with carbon 14 urea breath test in patients with vitiligo[J]. Turk J Med Sci, 2014, 44(6): 1051-1054. DOI: 10.3906/sag-1309-87.

40.Bakry OA, Basha M, El Hefnawy S, et al. Relationship between disease activity and Helicobacter pylori infection in patients with vitiligo[J]. Indian Dermatol Online J, 2018, 9(1): 59-61. DOI: 10.4103/idoj.IDOJ_77_17.

41.Mortazavi H, Hejazi P, Khamesipour A, et al. Frequency of seropositivity against infectious agents amongst pemphigus vulgaris patients: a case-control study on strongyloides stercoralis, Helicobacter pylori, toxoplasma gondii, leishmania major, and epstein-barr virus[J]. Int J Dermatol, 2015, 54(11): e458-65. DOI: 10.1111/ijd.12869.

42.Matsuo A, Tanaka R, Shiotani A, et al. Remission of sublamina densa-type linear IgA bullous dermatosis after Helicobacter pylori eradication[J]. Clin Exp Dermatol, 2009, 34(8): e988-9. DOI: 10.1111/j.1365-2230.2009.03631.x.